![]() ![]() ![]() (One of them, Eric Lenze, was in fact giving a presentation on fluvoxamine to the National Institutes of Health the next day.) Both of them encouraged anyone reading this article to get vaccinated. Reached by email, the two fluvoxamine investigators denied that there was any effort to suppress their research, and they were cautiously optimistic about their continued study. Instead, the government prefers to fund and promote new, proprietary drugs and vaccines, he says. That’s why they didn’t even fund the fluvoxamine trial,” he told me. When I asked him why so many experts in the field disagreed with him, he alleged there were efforts-either malicious or negligent-to suppress evidence of cheap, effective covid treatments. Since then, he has continued to promote fluvoxamine, along with ivermectin and hydroxychloroquine. ![]() They were giving covid patients the antidepressant fluvoxamine as soon as possible after diagnosis, based on anecdotes about the drug limiting the runaway immune response that causes many severe symptoms. Louis reached out to Kirsch looking for $67,000 to finish a very small-but placebo-controlled-trial. Drug researchers at Washington University in St. He wrote on his personal website that he’d been advised that being associated with the drug “would immediately trash my credibility.” A more promising candidateĪnother CETF grant, though, yielded far more exciting results. While he declined a phone interview, Boulware was recently the subject of a Mother Jones article about the harassment he’s received for his research on hydroxychloroquine and ivermectin.Ī few months ago, Kirsch suddenly stopped promoting hydroxychloroquine-even scrubbing it from the CETF’s official list of trials it has funded. ![]() “I disagree with his interpretation of the data regarding several medicines and strongly disagree with his anti-vaccine nonsense,” Boulware wrote to me. The results would, eventually, set Kirsch on a collision course with the scientific establishment.īoulware disputes that, and says that although Kirsch’s funding was important, his statements about drugs and vaccines have proven problematic. David Boulware, a researcher at the University of Minnesota, received $125,000 to test the drug against covid. One of the first CETF grants was to investigate the antimalarial hydroxychloroquine. “I think we did rigorous reviews of proposals for research.” “I agreed to do it partially because I respect Bob so much, and partially because I thought the concept was excellent,” said former board member Doug Richman, a prominent HIV drug researcher at the University of California San Diego and former member of the fund’s scientific advisory board. While Kirsch had the final say in who received grants, no one I spoke with expressed concerns about what projects had been funded, or why. (The fund borrows its nonprofit status from the 501(c)(3) Rockefeller Philanthropy Advisors, which managed its money until it quit, according to the Daily Beast neither organization is related to the Rockefeller Foundation, which supports Technology Review's reporting on covid.) To vet proposals, he recruited a powerhouse advisory board of prominent biologists, drug developers, and clinical researchers, led by world-renowned drug researcher Robert Siliciano of Johns Hopkins. Kirsch did a lot of things right when he set up CETF. So how did a man once intent on furthering science become a source of misinformation that undermines the very research he funded? In September, he resigned as CEO and gave up his board seat. Its board told him that if he wanted to remain part of the company he would have to stop making public anti-vaccine statements. Over the summer, the conflict reached his most recent startup, M10. In May, all 12 members of CETF’s scientific advisory board resigned, citing his alarming dangerous claims and erratic behavior. More recently, he’s adopted extremist positions on covid vaccines, which he alleges are “toxic.” He has claimed that one in 1,000 people who have received mRNA vaccines have died as a result, and even claimed the vaccines “kill more people than they save” at an FDA public forum, which was first reported by the Daily Beast.Īs Kirsch has gone deeper into the anti-vaccine scene, many professional associates have increasingly distanced themselves from him. And, according to three members of CETF’s scientific advisory board, he put pressure on them to promote fluvoxamine for clinical use without conclusive data that it worked for covid. He’s also publicly railed against what he claims is a campaign against drugs like fluvoxamine and ivermectin. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |